🔗 Permalink

Inventor profile of:

Benjamin Oshlack

City:

Boca Raton, Florida

Country:

United States

Published Applications:

104

Last publication date:

2020-05-07

Top Assignees for applications by Benjamin Oshlack

The entities that hold a legal rights for patent applications filed by inventor Oshlack Benjamin:

Purdue Pharma L.P. 69 Stamford, CT United States
Purdue Pharmaceuticals L.P. 60 Wilson, NC United States
The P.F. Laboratories, Inc. 60 Totowa, NJ United States
THE P.F. LABORATORIES 2 Totowa, NJ United States

Recent patent applications by Oshlack Benjamin

Benjamin Oshlack from Boca Raton, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2020-05-07

US20200138720A1

Human necessities

Pharmaceutical formulation containing gelling agent

#2 | 2019-11-21

US20190350868A1

Human necessities

Tamper resistant oral opioid agonist formulations

#3 | 2019-04-25

US20190117580A1

Human necessities

Pharmaceutical formulation containing gelling agent

#4 | 2019-04-18

US20190110996A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#5 | 2019-03-07

US20190070119A1

Human necessities

Pharmaceutical formulation containing gelling agent

#6 | 2019-01-24

US20190022086A1

Human necessities

CONTROLLED RELEASE HYDROCODONE FORMULATIONS

#7 | 2019-01-17

US20190015341A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#8 | 2018-12-13

US20180353502A1

Human necessities

CONTROLLED RELEASE HYDROCODONE FORMULATIONS

#9 | 2018-05-31

US20180147151A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#10 | 2018-05-10

US20180125788A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#11 | 2018-03-01

US20180055771A1

Human necessities

Pharmaceutical formulation containing gelling agent

#12 | 2018-02-15

US20180042859A1

Human necessities

Tamper resistant oral opioid agonist formulations

#13 | 2018-01-25

US20180021330A1

Human necessities

PHARMACEUTICAL FORMULATION CONTAINING OPIOID AGONIST, OPIOID ANTAGONIST AND GELLING AGENT

#14 | 2018-01-25

US20180021262A1

Human necessities

Pharmaceutical formulation containing gelling agent

#15 | 2017-11-30

US20170340626A1

Human necessities

Oxycodone formulations

#16 | 2017-10-19

US20170296533A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#17 | 2017-06-08

US20170157115A1

Human necessities

Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent

#18 | 2017-06-01

US20170151229A1

Human necessities

Methods of manufacturing oral formulations

#19 | 2017-05-25

US20170143697A1

Human necessities

Methods of providing analgesia

#20 | 2017-05-18

US20170136006A1

Human necessities

Methods of manufacturing oral dosage forms

#21 | 2017-05-18

US20170135959A1

Human necessities

Tamper resistant dosage form comprising co-extruded, adverse agent particles and process of making same

#22 | 2017-05-04

US20170119685A1

Human necessities

Tamper resistant oral opioid agonist formulations

#23 | 2017-04-27

US20170112765A1

Human necessities

Pharmaceutical formulation containing gelling agent

#24 | 2017-04-13

US20170100337A1

Human necessities

Naltrexone hydrochloride compositions

#25 | 2017-03-30

US20170087153A1

Human necessities

Controlled release hydrocodone formulations

#26 | 2017-03-30

US20170087152A1

Human necessities

Methods of providing analgesia

#27 | 2017-03-30

US20170087151A1

Human necessities

Controlled release hydrocodone formulations

#28 | 2017-03-09

US20170065525A1

Human necessities

Pharmaceutical formulation containing gelling agent

#29 | 2017-03-09

US20170065524A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#30 | 2017-01-26

US20170020864A1

Human necessities

Pharmaceutical formulation containing gelling agent

#31 | 2017-01-26

US20170020863A1

Human necessities

Pharmaceutical formulation containing gelling agent

#32 | 2016-11-03

US20160317456A1

Human necessities

PHARMACEUTICAL COMPOSITIONS

#33 | 2016-08-11

US20160228429A1

Human necessities

Controlled release hydrocodone formulations

#34 | 2016-06-09

US20160158224A1

Human necessities

Controlled release hydrocodone formulations

#35 | 2016-06-09

US20160158223A1

Human necessities

Controlled release hydrocodone formulations

#36 | 2016-06-02

US20160151502A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#37 | 2016-06-02

US20160151499A1

Human necessities

Pharmaceutical formulation containing gelling agent

#38 | 2016-06-02

US20160151361A1

Human necessities

Controlled release hydrocodone formulations

#39 | 2016-06-02

US20160151360A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#40 | 2016-06-02

US20160151358A1

Human necessities

Pharmaceutical formulation containing gelling agent

#41 | 2016-06-02

US20160151357A1

Human necessities

Pharmaceutical formulation containing gelling agent

#42 | 2016-06-02

US20160151356A1

Human necessities

Pharmaceutical formulation containing gelling agent

#43 | 2016-06-02

US20160151355A1

Human necessities

Pharmaceutical formulation containing gelling agent

#44 | 2016-06-02

US20160151297A1

Human necessities

Pharmaceutical formulation containing gelling agent

#45 | 2016-06-02

US20160151292A1

Human necessities

Controlled release hydrocodone formulations

#46 | 2016-06-02

US20160151291A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#47 | 2016-06-02

US20160151290A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#48 | 2016-06-02

US20160151289A1

Human necessities

Pharmaceutical formulation containing gelling agent

#49 | 2016-06-02

US20160151288A1

Human necessities

Controlled release hydrocodone formulations

#50 | 2016-06-02

US20160151277A1

Human necessities

Pharmaceutical formulation containing gelling agent

#51 | 2016-02-04

US20160030419A1

Human necessities

Oxycodone formulations

#52 | 2016-01-14

US20160008350A1

Human necessities

Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent

#53 | 2016-01-07

US20160000776A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#54 | 2016-01-07

US20160000723A1

Human necessities

Pharmaceutical formulation containing gelling agent

#55 | 2016-01-07

US20160000719A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#56 | 2016-01-07

US20160000718A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#57 | 2016-01-07

US20160000717A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#58 | 2016-01-07

US20160000712A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#59 | 2015-12-31

US20150374631A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#60 | 2015-12-31

US20150374628A1

Human necessities

Pharmaceutical formulation containing gelling agent

#61 | 2015-12-24

US20150366811A1

Human necessities

Pharmaceutical products

#62 | 2015-10-08

US20150283250A1

Human necessities

Pharmaceutical formulation containing gelling agent

#63 | 2015-10-08

US20150283130A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#64 | 2015-10-08

US20150283129A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#65 | 2015-10-08

US20150283128A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#66 | 2015-10-01

US20150273065A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#67 | 2015-10-01

US20150273064A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#68 | 2015-09-24

US20150265607A1

Human necessities

Pharmaceutical formulation containing gelling agent

#69 | 2015-09-24

US20150265606A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#70 | 2015-09-24

US20150265605A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#71 | 2015-09-24

US20150265604A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#72 | 2015-09-24

US20150265603A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#73 | 2015-09-24

US20150265602A1

Human necessities

Pharmaceutical formulation containing gelling agent

#74 | 2015-09-24

US20150265537A1

Human necessities

Controlled release hydrocodone formulations

#75 | 2015-09-17

US20150258090A1

Human necessities

Controlled release hydrocodone formulations

#76 | 2015-09-17

US20150258089A1

Human necessities

Controlled release hydrocodone formulations

#77 | 2015-08-27

US20150238481A1

Human necessities

Pharmaceutical formulation containing gelling agent

#78 | 2015-08-27

US20150238418A1

Human necessities

Controlled release hydrocodone formulations

#79 | 2015-08-20

US20150231131A1

Human necessities

Once-A day oxycodone formulations

#80 | 2015-08-20

US20150231086A1

Human necessities

Tamper-resistant oral opioid agonist formulations

#81 | 2015-08-06

US20150216810A1

Human necessities

Controlled release hydrocodone formulations

#82 | 2015-08-06

US20150216809A1

Human necessities

Controlled release hydrocodone formulations

#83 | 2015-07-02

US20150182628A1

Human necessities

Pharmaceutical formulation containing gelling agent

#84 | 2015-07-02

US20150182467A1

Human necessities

Tamper-resistant oral opioid agonist formulations

#85 | 2015-05-28

US20150148367A1

Human necessities

Controlled release hydrocodone formulations

#86 | 2015-05-28

US20150148319A1

Human necessities

Pharmaceutical formulation containing gelling agent

#87 | 2015-05-28

US20150147391A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#88 | 2015-05-21

US20150140083A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#89 | 2015-04-23

US20150110870A1

Human necessities

Controlled release hydrocodone formulations

#90 | 2015-01-29

US20150031718A1

Human necessities

Pharmaceutical Formulation Containing Opioid Agonist, Opioid Antagonist and Gelling Agent

#91 | 2015-01-01

US20150005333A1

Human necessities

Pharmaceutical formulation containing gelling agent

#92 | 2015-01-01

US20150005331A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#93 | 2014-12-18

US20140371257A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#94 | 2014-12-04

US20140357657A1

Human necessities

Pharmaceutical formulation containing gelling agent

#95 | 2014-08-14

US20140228390A1

Human necessities

Pharmaceutical formulation containing gelling agent

#96 | 2014-07-31

US20140213606A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#97 | 2013-11-14

US20130303494A1

Human necessities

Pharmaceutical formulation containing gelling agent

#98 | 2013-10-03

US20130261145A1

Human necessities

Pharmaceutical formulation containing gelling agent

#99 | 2013-10-03

US20130261144A1

Human necessities

Pharmaceutical formulation containing gelling agent

#100 | 2013-10-03

US20130261143A1

Human necessities

Pharmaceutical formulation containing gelling agent

InventorID:

403452 ⎘